Real-world outcomes of the Omnipod 5® hybrid closed loop system in adults with type 1 diabetes from a publicly funded service: deprivation does not influence glycaemic improvements

被引：0
|
作者：
Anandhakrishnan, A. [1 ,2 ]
Hyslop, R. [1 ]
Johnston, T. [1 ]
Bahadur, M. [1 ]
Atkinson, R. [1 ]
Pender, S. [1 ]
Liu, F. [1 ]
Kariyawasam, D. [1 ]
Brackenridge, A. [1 ]
Hussain, S. [1 ,2 ]
机构：
[1] Guys & St Thomas NHS Trust, Dept Diabet & Endocrinol, Guys Hosp, London, England
[2] Kings Coll London, Sch Cardiovasc Metab Med & Sci, Dept Diabet, London, England
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LBA 35
引用
收藏
页码：S525 / S526
页数：2
相关论文
共 50 条
  • [1] Real-world experience of Omnipod 5 hybrid closed loop system in a UK Diabetes centre
    Hussain, S.
    Willis, C.
    Anthony, L.
    Pichierri, J.
    Hume, C.
    Ford-Adams, M.
    Amin, R.
    Abraham, R.
    Choudhary, P.
    Greene, S.
    DIABETOLOGIA, 2024, 67 : S368 - S368
  • [2] Real-World Glycemic Improvements with Hybrid Closed Loop Pumps in Youth with Type 1 Diabetes
    Rolon, Maite E. Del Valle
    Brown, Elizabeth A.
    Wolf, Risa M.
    PEDIATRIC DIABETES, 2023, 2023
  • [3] Real-world experience of Omnipod 5 (OP5) hybrid closed loop (HCL) system in children and adolescents in a UK diabetes centre
    Greene, S.
    Willis, C.
    Anthony, L.
    Pichierri, J.
    Hume, C.
    Ford-Adams, M.
    Amin, R.
    Abraham, R.
    Choudhary, P.
    Hussain, S.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 228 - 228
  • [4] Real-World Glycemic Outcomes with Early Omnipod 5 Use in Youth with Type 1 Diabetes
    Marks, Brynn E.
    Meighan, Seema
    Zehra, Anum
    Douvas, Julia L.
    Rearson, Andrew
    Suresh, Reshma
    Brown, Elizabeth A.
    Wolf, Risa M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (11) : 782 - 789
  • [5] Long-term real-world outcomes of hybrid closed-loop therapy in adults with type 1 diabetes in the UK
    Liarakos, A. L.
    Crabtree, T. S. J.
    Griffin, T. P.
    Yap, Y. W.
    Narendran, P.
    Karamat, M.
    Gallen, G.
    Hussain, S.
    Elliott, J.
    Leelarathna, L.
    Lumb, A.
    Ryder, R. E. J.
    Choudhary, P.
    Wilmot, E. G.
    DIABETOLOGIA, 2024, 67 : S407 - S408
  • [6] What does upgrading from hybrid closed-loop systems to advanced hybrid closed-loop systems mean for children and adults with type 1 diabetes in real-world practice?
    Beato-Vibora, P.
    Gil-Poch, E.
    Arroyo-Diez, F. J.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S121 - S121
  • [7] REAL-WORLD USE OF CONTROL IQ HYBRID CLOSED-LOOP SYSTEM IN TYPE 1 DIABETES
    Jalowiecka, I.
    Sola Izquierdo, E.
    Marco Exposito, J. F.
    Banuls Morant, C.
    Morillas Arino, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A86 - A86
  • [8] Outcomes after 1 year in adults using Omnipod 5: Real-world data from a UK diabetes centre
    Stimson, Roland H.
    Strachan, Mark W. J.
    Dover, Anna R.
    Wright, Rohana J.
    Forbes, Shareen
    McRobert, Gayle
    Gibb, Fraser W.
    DIABETIC MEDICINE, 2024, 41 (12)
  • [9] Amelioration of user experiences and glycaemic outcomes with an Advanced Hybrid Closed Loop System in a real-world clinical setting
    Isabel Beato-Vibora, Pilar
    Gallego-Gamero, Fabiola
    Ambrojo-Lopez, Ana
    Gil-Poch, Estela
    Martin-Romo, Irene
    Javier Arroyo-Diez, Francisco
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178
  • [10] Real-world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed-loop use
    Berget, Cari
    Akturk, Halis Kaan
    Messer, Laurel H.
    Vigers, Timothy
    Pyle, Laura
    Snell-Bergeon, Janet
    Driscoll, Kimberly A.
    Forlenza, Gregory P.
    DIABETES OBESITY & METABOLISM, 2021, 23 (09): : 2048 - 2057
12345